These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9601114)

  • 21. Low Coverage and Disparities of Breast and Cervical Cancer Screening in Thai Women: Analysis of National Representative Household Surveys.
    Mukem S; Meng Q; Sriplung H; Tangcharoensathien V
    Asian Pac J Cancer Prev; 2015; 16(18):8541-51. PubMed ID: 26745114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing breast and cervical cancer screening in low-income women.
    Margolis KL; Lurie N; McGovern PG; Tyrrell M; Slater JS
    J Gen Intern Med; 1998 Aug; 13(8):515-21. PubMed ID: 9734787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic disease as a barrier to breast and cervical cancer screening.
    Kiefe CI; Funkhouser E; Fouad MN; May DS
    J Gen Intern Med; 1998 Jun; 13(6):357-65. PubMed ID: 9669564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 27. Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006-2014.
    Kriaucioniene V; Petkeviciene J
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31744058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Attendance in the second phase (2004-2005) of the Hungarian organized breast cancer screening program].
    Boncz I; Sebestyén A; Döbrossy L; Péntek Z; Kovács A; Budai A; Kövi R; Ember I
    Orv Hetil; 2008 Aug; 149(32):1491-8. PubMed ID: 18672438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast and cervical cancer screening among underserved women. Baseline survey results from six states. The National Cancer Institute Cancer Screening Consortium for Underserved Women.
    Arch Fam Med; 1995 Jul; 4(7):617-24. PubMed ID: 7606299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stat bite: Cancer screening for women.
    J Natl Cancer Inst; 2007 Feb; 99(4):271. PubMed ID: 17312303
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective study of predictors of attendance for breast screening in inner London.
    Sutton S; Bickler G; Sancho-Aldridge J; Saidi G
    J Epidemiol Community Health; 1994 Feb; 48(1):65-73. PubMed ID: 8138773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraception and screening for cervical and breast cancer in neuromuscular disease: a retrospective study of 50 patients monitored at a clinical reference centre.
    Goutard S; Baron C; Bouton C; Penisson-Besnier I; Fossé G; Aube-Nathier AC; Havet-Thomassin V; Dubas F; Richard I
    Ann Phys Rehabil Med; 2009; 52(7-8):538-45. PubMed ID: 19709942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of geographic origin on gynecological cancer screening in Spain.
    Sanz-Barbero B; Regidor E; Galindo S
    Rev Saude Publica; 2011 Dec; 45(6):1019-26. PubMed ID: 22124736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do cervical cancer screening rates increase in association with an intervention designed to increase mammography usage?
    Katz ML; Tatum CM; Degraffinreid CR; Dickinson S; Paskett ED
    J Womens Health (Larchmt); 2007; 16(1):24-35. PubMed ID: 17324094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake of breast screening. May be influenced by practice specific factors.
    Hollyoak V
    BMJ; 1995 Apr; 310(6985):1004. PubMed ID: 7727998
    [No Abstract]   [Full Text] [Related]  

  • 38. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women.
    Buki LP; Jamison J; Anderson CJ; Cuadra AM
    Cancer; 2007 Oct; 110(7):1578-85. PubMed ID: 17696119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of selected environmental factors on attendance in the Breast and Cervical Cancer Early Detection Programme in the Wielkopolska Province of Poland during 2007-2012.
    Kycler W; Kubiak A; Rzymski P; Wilczak M; Trojanowski M; Roszak M; Włoszczak-Szubzda A; Rzymska I
    Ann Agric Environ Med; 2017 Sep; 24(3):467-471. PubMed ID: 28954492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution of West Virginia women targeted for screening of breast and cervical cancers.
    German RR
    W V Med J; 1996; 92(2):82-6. PubMed ID: 8857175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.